Scinai Immunotherapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
Revenue | $487 | $277 | $386 |
Gross Profit | -1,114 | -635 | |
EBITDA | -2,008 | -963 | -1,529 |
EBIT | -2,460 | -1,881 | |
Net Income | 3,567 | -2,119 | -2,067 |
Net Change In Cash | 487 | 277 | 386 |
Free Cash Flow | -1,455 | -1,734 | -1,537 |
Cash | 3,114 | 1,661 | 989 |
Basic Shares | 159 | 159 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,311 | $658 | $0 | $0 |
Gross Profit | -2,652 | -580 | -512 | -559 |
EBITDA | -6,527 | -6,989 | -9,192 | -10,499 |
EBIT | -7,948 | -8,638 | -9,706 | -11,061 |
Net Income | -8,307 | 4,796 | -6,500 | -5,796 |
Net Change In Cash | 1,311 | 658 | 0 | 0 |
Free Cash Flow | -6,055 | -6,347 | -10,019 | -8,101 |
Cash | 1,661 | 1,964 | 4,870 | 14,075 |
Basic Shares | 233 | 80 | 39 | 18 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.74 |
2026-03-31 | $0.94 |
2025-09-30 | -$2.48 |
2025-06-30 | -$2.60 |